You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Best Practice Recommendations for Regimen Development and Maintenance

ID: GL-C50-25 Feb 2016
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
CCO Drug Formulary

Guideline Objective

A group of experts from across Ontario developed consensus-based recommendations on the development and maintenance of oncology regimens. These recommendations apply to both intravenous and oral cancer medications, as well as clinical trial regimens for cancer.

Intended Guideline Users

Providers (Physicians, Pharmacists, Nurses)

pdf download Full Report (PDF) (1019.33 KB)